Walleye Capital LLC Avrobio, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.15 - $1.48 $155,989 - $200,751	135,643 New	135,643 $173,000
Q2 2022 Aug 08, 2022	SELL	$0.75 - $1.33 $149,194 - $264,571	-198,926 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.29 - $4.04 $69,359 - $217,218	53,767 Added 37.04%	198,926 $263,000
Q4 2021 Mar 03, 2022	BUY	$3.45 - $6.05 $90,690 - $159,036	26,287 Added 22.11%	145,159 $558,000
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $657,362 - $1.1 Million	118,872 New	118,872 $663,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.